Genetic basis for increased intestinal permeability in families with Crohn's disease: role of CARD15 3020insC mutation?

od Buhner, S, Buning, C, Genschel, J, Kling, K, Herrmann, D, Dignass, A, Kuechler, I, Krueger, S, Schmidt, H H‐J, Lochs, H
Wydane 2006

Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long‐term extension data from a Phase 3 study

od Schmidt, C., Ahmad, T., Tulassay, Z., Baumgart, D. C., Bokemeyer, B., Howaldt, S., Stallmach, A., Büning, C., Baumgart, Daniel C., Bokemeyer, Bernd, Büning, Carsten, Helwig, Ulf, Howaldt, Stefanie, Hüppe, Dietrich, Krummenerl, Annette, Krummenerl, Thomas, Kühbacher, Tanja, Landry, Wilfried, Lügering, Andreas, Maaser, Christian, Mroß, Michael, Seidler, Ursula, Stallmach, Andreas, Stein, Jürgen, Teich, Niels, Horvath, Gabor, Kristóf, Tünde, László, András, Molnár, Tamás, Salamon, Ágnes, Tulassay, Zsolt, Vincze, Áron, Krayenbuehl, Pierre, Ahmad, Tariq, Beales, Ian, Brookes, Matthew, Campbell, Simon, Cummings, Fraser, Ede, Ronald, Elphick, David, Ireland, Alan, Kejariwal, Deepak, Li, Andy, Mansfield, John
Wydane w Aliment Pharmacol Ther (2016)